Exogenous Reinfection of Tuberculosis in Taiwan
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
we hypothesize that exogenous reinfection is very important in the Taiwan endemic. Therefore, we design a series of studies to evaluate the individual contribution of exogenous reinfection and endogenous reactivation in the Taiwan endemic, and to realize the impact of exogenous reinfection. First, we will identify the patients with TB relapse after complete treatment. The M. tuberculosis isolates responsible for their initial and recurrent episodes will then be genotyped to clarify the percentage of exogenous reinfection and endogenous reinfection. In addition, we will try to detect the dormant M. tuberculosis bacilli in the lung tissue from patients just finished their anti-TB treatment by using highly sensitive molecular biologic methods to show the possibility of reactivation after complete treatment is low. Finally, we will prospectively survey the health care workers in a medical center by using chest radiograph at the 3rd weeks, and tuberculin skin test at the 3rd and 11th weeks after they expose to smear-negative culture-positive cases of TB. For those with abnormal findings, surveillance sputum mycobacterial studies will be performed. Once yielding M. tuberculosis, the isolates will be genotyped and compare with the DNA fingerprints of the index cases to demonstrate the transmission of TB.
| Condition |
|---|
|
Tuberculosis |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Retrospective/Prospective |
| Official Title: | The Importance of Exogenous Reinfection in the Tuberculosis Endemic of Taiwan |
| Estimated Enrollment: | 150 |
| Study Start Date: | January 1999 |
| Estimated Study Completion Date: | June 2007 |
Tuberculosis (TB) remains the most important infectious disease in the world. In Taiwan, the incidence of TB increased in recent years. The failure of control implies the necessity to reevaluate the epidemiology of Mycobacterium tuberculosis. It is widely thought that most cases of TB are caused by reactivation of a latent infection. Treatment programs have therefore focused on cure rates rather than tracking of additional cases. But recent studies showed that exogenous reinfection plays an important role in the development of TB. In addition, it seems that the higher the local incidence, the more important exogenous reinfection is. The question of exogenous reinfection versus endogenous reactivation has an impact on the distribution of resources for the prevention and treatment of TB. Based on these evidences, we hypothesize that exogenous reinfection is very important in the Taiwan endemic. Therefore, we design a series of studies to evaluate the individual contribution of exogenous reinfection and endogenous reactivation in the Taiwan endemic, and to realize the impact of exogenous reinfection. First, we will identify the patients with TB relapse after complete treatment. The M. tuberculosis isolates responsible for their initial and recurrent episodes will then be genotyped to clarify the percentage of exogenous reinfection and endogenous reinfection. In addition, we will try to detect the dormant M. tuberculosis bacilli in the lung tissue from patients just finished their anti-TB treatment by using highly sensitive molecular biologic methods to show the possibility of reactivation after complete treatment is low. Finally, we will prospectively survey the health care workers in a medical center by using chest radiograph at the 3rd weeks, and tuberculin skin test at the 3rd and 11th weeks after they expose to smear-negative culture-positive cases of TB. For those with abnormal findings, surveillance sputum mycobacterial studies will be performed. Once yielding M. tuberculosis, the isolates will be genotyped and compare with the DNA fingerprints of the index cases to demonstrate the transmission of TB.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- culture-proven tuberculosis with recurrence
Contacts and Locations| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan, 100 | |
| Contact: Jann-Yuan Wang, MD 886-2-2356-2905 jywang@ntu.edu.tw | |
| Contact: Pan-Chyr Yang, PhD 886-2-2356-2905 pcyang@ha.mc.ntu.edu.tw | |
| Principal Investigator: Jann-Yuan Wang, MD | |
| Principal Investigator: | Jann-Yuan Wang, MD | National Taiwan University Hospital |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00173433 History of Changes |
| Other Study ID Numbers: | 9461700627 |
| Study First Received: | September 12, 2005 |
| Last Updated: | December 20, 2005 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by National Taiwan University Hospital:
|
tuberculosis relapse reinfection |
reactivation dormancy tuberculin skin test |
Additional relevant MeSH terms:
|
Tuberculosis Mycobacterium Infections Actinomycetales Infections Gram-Positive Bacterial Infections Bacterial Infections |
ClinicalTrials.gov processed this record on May 21, 2013